Nature Reviews Immunology, volume 22, issue 2, pages 112-123

Natural killer cells in antiviral immunity

Publication typeJournal Article
Publication date2021-06-11
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor100.3
ISSN14741733, 14741741
Energy Engineering and Power Technology
Fuel Technology
Abstract
Natural killer (NK) cells play an important role in innate immune responses to viral infections. Here, we review recent insights into the role of NK cells in viral infections, with particular emphasis on human studies. We first discuss NK cells in the context of acute viral infections, with flavivirus and influenza virus infections as examples. Questions related to activation of NK cells, homing to infected tissues and the role of tissue-resident NK cells in acute viral infections are also addressed. Next, we discuss NK cells in the context of chronic viral infections with hepatitis C virus and HIV-1. Also covered is the role of adaptive-like NK cell expansions as well as the appearance of CD56− NK cells in the course of chronic infection. Specific emphasis is then placed in viral infections in patients with primary immunodeficiencies affecting NK cells. Not least, studies in this area have revealed an important role for NK cells in controlling several herpesvirus infections. Finally, we address new data with respect to the activation of NK cells and NK cell function in humans infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) giving rise to coronavirus disease 2019 (COVID-19). This Review covers the role of natural killer cells in acute and chronic viral infections, with emphasis on human infections and insights from patients with primary immunodeficiencies affecting natural killer cells. It also describes the emerging data on how natural killer cells are involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Top-30

Citations by journals

5
10
15
20
25
30
35
Frontiers in Immunology
32 publications, 14.1%
Nature Immunology
5 publications, 2.2%
Signal Transduction and Targeted Therapy
4 publications, 1.76%
Nature Communications
4 publications, 1.76%
Viruses
3 publications, 1.32%
Biomedicines
3 publications, 1.32%
International Journal of Molecular Sciences
3 publications, 1.32%
Current Opinion in HIV and AIDS
2 publications, 0.88%
Frontiers in Pharmacology
2 publications, 0.88%
Frontiers in Cellular and Infection Microbiology
2 publications, 0.88%
Molecular Medicine
2 publications, 0.88%
Cell Reports
2 publications, 0.88%
International Immunopharmacology
2 publications, 0.88%
Current Opinion in Immunology
2 publications, 0.88%
Cell Reports Medicine
2 publications, 0.88%
Journal for ImmunoTherapy of Cancer
2 publications, 0.88%
Journal of Inflammation Research
2 publications, 0.88%
Journal of Infectious Diseases
2 publications, 0.88%
Journal of Virology
2 publications, 0.88%
Proceedings of the National Academy of Sciences of the United States of America
2 publications, 0.88%
eLife
2 publications, 0.88%
European Journal of Immunology
2 publications, 0.88%
Immunological Reviews
2 publications, 0.88%
Nutrients
2 publications, 0.88%
Cell Communication and Signaling
2 publications, 0.88%
Diagnostics
2 publications, 0.88%
Chinese Medical Journal
2 publications, 0.88%
Advanced Materials
2 publications, 0.88%
Nature
2 publications, 0.88%
5
10
15
20
25
30
35

Citations by publishers

5
10
15
20
25
30
35
40
Springer Nature
39 publications, 17.18%
Frontiers Media S.A.
37 publications, 16.3%
Elsevier
35 publications, 15.42%
Multidisciplinary Digital Publishing Institute (MDPI)
23 publications, 10.13%
Wiley
23 publications, 10.13%
Cold Spring Harbor Laboratory
12 publications, 5.29%
Wolters Kluwer Health
7 publications, 3.08%
Taylor & Francis
3 publications, 1.32%
Oxford University Press
3 publications, 1.32%
American Society for Microbiology
3 publications, 1.32%
Mary Ann Liebert
2 publications, 0.88%
Feinstein Institute for Medical Research
2 publications, 0.88%
BMJ
2 publications, 0.88%
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 0.88%
eLife Sciences Publications
2 publications, 0.88%
SAGE
2 publications, 0.88%
Baishideng Publishing Group
2 publications, 0.88%
Begell House
1 publication, 0.44%
American Society for Clinical Investigation
1 publication, 0.44%
Korean Society of Food Science and Technology
1 publication, 0.44%
Future Medicine
1 publication, 0.44%
IOP Publishing
1 publication, 0.44%
Portland Press
1 publication, 0.44%
American Institute of Physics (AIP)
1 publication, 0.44%
American Chemical Society (ACS)
1 publication, 0.44%
Dove Medical Press
1 publication, 0.44%
Publishing House ABV Press
1 publication, 0.44%
American Society for Biochemistry and Molecular Biology
1 publication, 0.44%
American Association for the Advancement of Science (AAAS)
1 publication, 0.44%
5
10
15
20
25
30
35
40
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Björkström N. K., Strunz B., LJUNGGREN H. Natural killer cells in antiviral immunity // Nature Reviews Immunology. 2021. Vol. 22. No. 2. pp. 112-123.
GOST all authors (up to 50) Copy
Björkström N. K., Strunz B., LJUNGGREN H. Natural killer cells in antiviral immunity // Nature Reviews Immunology. 2021. Vol. 22. No. 2. pp. 112-123.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41577-021-00558-3
UR - https://doi.org/10.1038/s41577-021-00558-3
TI - Natural killer cells in antiviral immunity
T2 - Nature Reviews Immunology
AU - Björkström, Niklas K.
AU - Strunz, Benedikt
AU - LJUNGGREN, HANS-GUSTAF
PY - 2021
DA - 2021/06/11 00:00:00
PB - Springer Nature
SP - 112-123
IS - 2
VL - 22
SN - 1474-1733
SN - 1474-1741
ER -
BibTex |
Cite this
BibTex Copy
@article{2021_Björkström,
author = {Niklas K. Björkström and Benedikt Strunz and HANS-GUSTAF LJUNGGREN},
title = {Natural killer cells in antiviral immunity},
journal = {Nature Reviews Immunology},
year = {2021},
volume = {22},
publisher = {Springer Nature},
month = {jun},
url = {https://doi.org/10.1038/s41577-021-00558-3},
number = {2},
pages = {112--123},
doi = {10.1038/s41577-021-00558-3}
}
MLA
Cite this
MLA Copy
Björkström, Niklas K., et al. “Natural killer cells in antiviral immunity.” Nature Reviews Immunology, vol. 22, no. 2, Jun. 2021, pp. 112-123. https://doi.org/10.1038/s41577-021-00558-3.
Found error?